08:48 AM EDT, 03/25/2025 (MT Newswires) -- Health care stocks were advancing premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) marginally higher.

Alumis ( ALMS ) shares were up over 65% after the company and Kaken Pharmaceutical said they signed a collaboration and licensing agreement to develop, manufacture, and commercialize ESK-001 for dermatology indications in Japan, with an option to expand the license to include rheumatological and gastrointestinal diseases.